Evaluation of the Abbott i-STAT TBI Biomarker Test
Key facts
- Who runs it
- Icahn School of Medicine at Mount Sinai
- Where
- New York, United StatesSee the 3 sites
- Trial code
- Status
- Terminated
- People taking part
- 42 people enrolled
- Started
- 30 Jan 2025
- Ended
- 30 May 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- i-STAT TBI Test
- Record updated
- 15 October 2026
- Why it stopped
- Study was terminated early due to recruitment limitations and available funding for continued recruitment and follow up
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age ≥18 years
- Head injury within 24 hours of research blood collection
- CT head ordered as part of routine care, not yet completed
- Glasgow Coma Scale (GCS) 13 - 15
Who cannot take part
- Previously enrolled in this study in the past 30 days
- Suspected current ischemic or hemorrhagic stroke
- History of multiple sclerosis
- Unknown whether head injury occurred, and signs of head injury are absent
- Prisoner or in police custody or known pregnancy
- Suspected open or depressed skull fracture, or signs of skull base fracture
- Venipuncture not feasible
Where in United States
- Mount Sinai HospitalNew York, United States
- Mount Sinai MorningsideNew York, United States
- Mount Sinai WestNew York, United States
About the trial
What the trial wants to find out
According to the Centers for Disease Control and Prevention, approximately 200,000 hospitalizations occurred in 2020 related to Traumatic Brain Injury (TBI), which does not include many TBIs treated only in emergency departments, urgent care, primary care, or that are not evaluated by a clinician. Head CT is a critical component of care for severe TBI, however in mild TBI there is practice variation with a wider risk to benefit estimation for obtaining head CT imaging. Potential disadvantages of head CT include longer Emergency Department (ED) length of stay (LOS), higher costs, and diagnostic radiation exposure. The i-STAT TBI test is a panel of in vitro diagnostic immunoassays for the quantitative measurements of glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) in whole blood and a semi-quantitative interpretation of test results derived from these measurements, using the i-STAT Alinity instrument. This biomarker test is cleared for use in adults with mild TBI (Glasgow Coma Scale 13-15) within 24 hours of injury, to aid in determining the need for head CT imaging. Currently, CT head imaging for adults with suspected mild TBI is obtained based on clinicians' usual practice patterns and beliefs about patient expectations. Prior research has demonstrated the blood TBI test may reduce unnecessary CT scans by up to 40%, however the impact on head CT ordering has not yet been studied prospectively. It is important to understand the extent to which a negative TBI biomarker result empowers a clinician to cancel a previously ordered head CT. Given that adult patients with mild TBI often present to EDs, which have access to CT scanners, this is a key setting to assess real-world impact of the i-STAT TBI test on CT head utilization.
The 2 groups in the trial
- Notification Arm (Abbott iSTAT TBI test)Treatment being tested
The ED clinicians caring for the enrolled patient, along with the patient, receive the TBI blood test result with just-in-time education on the TBI test to aid in clinical decision making.
Treatment: i-STAT TBI Test
- Non-Notification Arm (Control)No study treatment, for comparison
Clinicians and enrolled patients do not receive the TBI blood test result.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluation of the Abbott i-STAT TBI Biomarker Test for Effect on Decreasing CT Utilization Among Adult Emergency Department Patients With Suspected Traumatic Brain Injury
- Record updated
- 15 October 2026